Revenue | ₹1,301.51Cr |
Net Profits | ₹202.11Cr |
Net Profit Margins | 15.53% |
Strides Pharma Science Ltd’s revenue jumped 12.18% since last year same period to ₹1,301.51Cr in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 4.29% jump in its revenue since last 3-months.
Strides Pharma Science Ltd’s net profit jumped 129.8% since last year same period to ₹202.11Cr in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 58.48% jump in its net profits since last 3-months.
Strides Pharma Science Ltd’s net profit margin jumped 104.86% since last year same period to 15.53% in the Q3 2025-2026. On a quarterly growth basis, Strides Pharma Science Ltd has generated 51.96% jumped in its net profit margins since last 3-months.
The revenue for Strides Pharma Science Ltd in the Q3 results 2025 was ₹1,301.51Cr.
The net profit for Strides Pharma Science Ltd in the Q3 results 2025 was ₹202.11Cr.
The net profit margin for Strides Pharma Science Ltd in the Q3 results 2025 was 15.53%.
The revenue for Strides Pharma Science Ltd in the Q3 results 2024 was ₹1,160.24Cr.
The net profit for Strides Pharma Science Ltd in the Q3 results 2024 was ₹87.95Cr.
The net profit margin for Strides Pharma Science Ltd in the Q3 results 2024 was 7.58%.